• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Mankind Share Price

    Mankind Pharma Share PriceMankind Pharma

    Large Cap 5.8k Result
    ₹1750.7
    8.15 (0.47%)
    • Advice
    • Hold
    As on 26 September, 2023 | 23:51 BSE: 543904 NSE: MANKINDISIN: INE634S01028

    Mankind Pharma Performance

    Day Range

    • Low 1747.05
    • High 1776.55
    1750.7

    52 Week Range

    • Low 1242
    • High 1949
    1750.7
    • Open Price1776.1
    • Previous Close1742.55
    • Volume84803

    Start SIP in Mankind Pharma

    Start SIP

    Mankind Pharma Share Price

    • Over 1 Month -1.94%
    • Over 3 Month 2.81%

    Mankind Pharma Key Statistics

    P/E Ratio
    PEG Ratio
    Market Cap Cr 70,131
    Price to Book Ratio 9.2
    EPS 30.4
    Dividend 0
    Relative Strength Index 46.56
    Money Flow Index 66.23
    MACD Signal -11.26
    Average True Range 45.07

    Mankind Pharma Investment Rating

    • Master Rating:

    • Mankind Pharma Ltd has an operating revenue of Rs. 8,447.98 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 19% is great, ROE of 17% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 10% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 43 which is a POOR score indicating inconsistency in earnings, a RS Rating of 47 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 111 indicates it belongs to a poor industry group of Medical-Products and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Mankind Pharma Financials
    IndicatorJun 2023Mar 2023Dec 2022Mar 2022
    Oper Rev Qtr Cr 2,3001,8721,9361,645
    Operating Expenses Qtr Cr 1,7611,4911,5631,336
    Operating Profit Qtr Cr 539381373309
    Depreciation Qtr Cr 69677136
    Interest Qtr Cr 21911
    Tax Qtr Cr 117747753
    Net Profit Qtr Cr 409281249217
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 8,2907,420
    Operating Expenses Annual Cr 6,4305,457
    Operating Profit Annual in Cr 1,6971,800
    Depreciation Cr 270121
    Interest Annual Cr 2844
    Tax Annual Cr 315462
    Net Profit Annual Cr 1,2481,335
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 1,799812
    Cash from Investing Activity Annual Cr -1,041-1,369
    Cash from Financing Annual Activity Cr -710579
    Net Cash Flow Annual Cr 4822
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 7,7846,069
    Fixed Assets Annual Cr 3,6373,273
    Total Non Current Assets Annual Cr 5,8545,156
    Total Current Assets Annual Cr 3,5173,257
    Total Assets Annual Cr 9,3718,413
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 194151
    ROE Annual % 1622
    ROCE Annual % 2030
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2327
    IndicatorJun 2023Mar 2023Dec 2022Mar 2022
    Oper Rev Qtr Cr 2,5792,0532,0911,726
    Operating Expenses Qtr Cr 1,9241,6361,6541,441
    Operating Profit Qtr Cr 655417437285
    Depreciation Qtr Cr 87858547
    Interest Qtr Cr 651313
    Tax Qtr Cr 130848370
    Net Profit Qtr Cr 494285284190
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 8,8787,978
    Operating Expenses Annual Cr 6,8495,792
    Operating Profit Annual in Cr 1,9011,989
    Depreciation Cr 326167
    Interest Annual Cr 4459
    Tax Annual Cr 362522
    Net Profit Annual Cr 1,2821,433
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 1,813920
    Cash from Investing Activity Annual Cr -1,054-1,369
    Cash from Financing Annual Activity Cr -740605
    Net Cash Flow Annual Cr 19155
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 7,4356,155
    Fixed Assets Annual Cr 4,7814,269
    Total Non Current Assets Annual Cr 5,3884,741
    Total Current Assets Annual Cr 4,3284,407
    Total Assets Annual Cr 9,7159,148
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 190158
    ROE Annual % 1723
    ROCE Annual % 2231
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2328

    Mankind Pharma Technicals

    EMA & SMA

    Current Price
    ₹1750.7
    8.15 (0.47%)
    • Bullish Moving Average
    • ___
    • 2
    • Bearish Moving Average
    • ___
    • 9
    • 20 Day
    • ₹1765.97
    • 50 Day
    • ₹1751.09
    • 100 Day
    • ₹
    • 200 Day
    • ₹
    • 20 Day
    • ₹1764.76
    • 50 Day
    • ₹1805.62
    • 100 Day
    • ₹
    • 200 Day
    • ₹

    Mankind Pharma Resistance and Support

    PIVOT
    ₹1758.1
    Resistance
    First Resistance ₹1769.15
    Second Resistance ₹1787.6
    Third Resistance ₹1798.65
    RSI 46.56
    MFI 66.23
    MACD Single Line -11.26
    MACD -13.87
    Support
    First Resistance ₹1739.65
    Second Resistance ₹1728.6
    Third Resistance ₹1710.15

    Mankind Pharma Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 88,665 5,095,578 57.47
    Week 198,488 13,947,738 70.27
    1 Month 280,543 19,851,233 70.76
    6 Month 750,403 40,604,315 54.11

    Mankind Pharma Result Highlights

    Mankind Pharma Synopsis

    NSE-Medical-Products

    Mankind Pharma is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 8127.15 Cr. and Equity Capital is Rs. 40.06 Cr. for the Year ended 31/03/2023. Mankind Pharma Ltd. is a Public Limited Listed company incorporated on 03/07/1991 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is U74899DL1991PLC044843 and registration number is 044843.
    Market Cap 70,131
    Sales 6,109
    Shares in Float 9.61
    No of funds 177
    Yield
    Book Value 9.01
    U/D Vol ratio 1.2
    LTDebt / Equity
    Alpha 0.29
    Beta -0.52

    Mankind Pharma

    Owner NameJun-23May-23
    Promoters 76.5%76.5%
    Mutual Funds 3.92%1.83%
    Insurance Companies 0.55%0.51%
    Foreign Portfolio Investors 4.18%2.61%
    Financial Institutions/ Banks 0.09%
    Individual Investors 1.02%4.15%
    Others 13.83%14.31%

    Mankind Pharma Management

    Name Designation
    Mr. Ramesh Juneja Chairman & Wholetime Director
    Mr. Rajeev Juneja Vice Chairman & Mng.Director
    Ms. Sheetal Arora WholeTime Director & CEO
    Mr. Satish Kumar Sharma Whole Time Director
    Mr. Vivek Kalra Independent Director
    Mr. Tilokchand Punamchand Ostwal Independent Director
    Mr. Surendra Lunia Independent Director
    Mr. Bharat Anand Independent Director
    Mr. Vijaya Sampath Independent Director

    Mankind Pharma Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Mankind Pharma Corporate Action

    Date Purpose Remarks
    2023-08-02 Quarterly Results
    2023-05-30 Audited Results

    Mankind Pharma MF Shareholding

    Name Amount(cr)
    HDFC Mid-Cap Opportunities Fund Growth 47236
    SBI Bluechip Fund Regular Growth 38881
    Kotak Emerging Equity Scheme Growth 33091
    Axis Long Term Equity Fund Growth 31411
    HDFC Top 100 Fund Growth 25423
    • Company Name
    • CMP
    • Chg(%)
    • Company Name
    • CMP
    • Chg(%)

    Mankind Pharma FAQs

    What is Share Price of Mankind Pharma ?

    Mankind Pharma share price is ₹1750 As on 26 September, 2023 | 23:37

    What is the Market Cap of Mankind Pharma ?

    The Market Cap of Mankind Pharma is ₹70131 Cr As on 26 September, 2023 | 23:37

    What is the P/E ratio of Mankind Pharma ?

    The P/E ratio of Mankind Pharma is As on 26 September, 2023 | 23:37

    What is the PB ratio of Mankind Pharma ?

    The PB ratio of Mankind Pharma is 9.2 As on 26 September, 2023 | 23:37

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.